| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 541.37M | 435.63M | 521.02M | 363.88M | 337.40M | 544.22M |
| Gross Profit | 539.44M | 435.63M | 519.94M | 51.89M | 64.27M | 154.33M |
| EBITDA | 220.47M | 245.09M | 224.28M | 168.06M | 151.25M | 170.84M |
| Net Income | 91.19M | 95.34M | 83.55M | 32.27M | 70.35M | 61.06M |
Balance Sheet | ||||||
| Total Assets | 1.44B | 1.48B | 1.30B | 1.05B | 1.12B | 685.93M |
| Cash, Cash Equivalents and Short-Term Investments | 146.42M | 126.28M | 154.63M | 463.19M | 600.49M | 158.00M |
| Total Debt | 676.86M | 758.36M | 588.13M | 325.13M | 218.85M | 225.21M |
| Total Liabilities | 1.33B | 1.37B | 1.17B | 903.99M | 828.16M | 416.74M |
| Stockholders Equity | 114.73M | 112.79M | 128.84M | 145.58M | 291.43M | 269.19M |
Cash Flow | ||||||
| Free Cash Flow | -36.97M | -78.98M | -127.63M | 8.30M | 110.69M | 185.03M |
| Operating Cash Flow | -35.03M | -59.70M | -106.00M | 24.61M | 119.94M | 194.97M |
| Investing Cash Flow | -23.06M | -26.68M | -1.35M | -16.31M | -42.39M | -8.06M |
| Financing Cash Flow | 108.98M | 59.67M | 162.02M | -71.52M | -74.06M | -120.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $1.11B | 13.17 | 31.30% | 6.18% | 11.64% | 18.08% | |
| ― | AU$1.70B | 29.41 | 30.67% | 0.96% | 12.62% | 12.46% | |
| ― | AU$31.67M | 14.57 | 7.05% | 4.73% | -7.29% | 60.64% | |
| ― | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
| ― | €1.21B | 12.66 | 79.56% | 8.62% | 7.99% | 14.07% | |
| ― | AU$97.65M | -7.41 | -8.39% | ― | -6.45% | -364.91% | |
| ― | AU$14.84M | -0.90 | ― | ― | 14.07% | -157.40% |
McMillan Shakespeare Limited has announced the appointment of Michelle Siekierka as the new Company Secretary, effective immediately. Siekierka, who joined the company in September 2025 as General Counsel, brings extensive experience in corporate and commercial law, as well as risk and compliance management, having previously worked with organizations such as Growthpoint Properties Australia and the Treasury Corporation of Victoria. Her appointment is expected to strengthen the company’s governance and compliance functions, enhancing its communication with the ASX and potentially impacting its operational efficiency and stakeholder relations.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$17.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has announced its 2025 Annual General Meeting (AGM) will be held on 17 November 2025 as a hybrid event, allowing shareholders to participate either in person or online. This format aims to maximize accessibility for stakeholders. The AGM will include a review of the company’s performance for the financial year ended 30 June 2025, and shareholders will consider various resolutions as outlined in the meeting’s Notice and Explanatory Notes.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$17.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has released its 2025 Sustainability Report, highlighting its commitment to sustainable practices and corporate responsibility. This announcement underscores the company’s ongoing efforts to integrate sustainability into its operations, potentially strengthening its market position and enhancing stakeholder trust.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$17.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited announced a change in the director’s interest, specifically regarding Roberto De Luca. The changes include the acquisition of 5,884 share rights as incentive-based remuneration and the conversion and lapsing of performance rights. This adjustment in director interests reflects the company’s ongoing commitment to aligning executive incentives with shareholder interests, potentially impacting its governance and stakeholder confidence.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$21.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited announced the cessation of certain securities, specifically 29,962 performance rights and 2,096 share rights, due to unmet conditions. This development may impact the company’s capital structure and reflects the challenges in meeting the conditions tied to these securities, potentially affecting stakeholder confidence and market perception.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$21.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
Mcmillan Shakespeare Limited has announced the issuance of 5,884 unquoted equity securities under an employee incentive scheme. This issuance, which is not intended to be quoted on the ASX, reflects the company’s ongoing efforts to incentivize its workforce and align employee interests with company performance.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$21.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
Mcmillan Shakespeare Limited announced the issuance of 14,407 unquoted share rights under an employee incentive scheme, effective from September 12, 2025. This move is part of the company’s strategy to motivate and retain its workforce, potentially enhancing employee engagement and aligning their interests with the company’s long-term goals.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$21.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
Mcmillan Shakespeare Limited announced a dividend distribution of AUD 0.77 per share for its ordinary fully paid shares. The dividend relates to the six-month financial period ending on June 30, 2025, with an ex-date of September 11, 2025, and a payment date of September 26, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may influence its market positioning by demonstrating financial stability and shareholder confidence.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$16.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has announced its FY25 Results Investor Presentation to the Australian Securities Exchange. This announcement, authorized by the MMS Board, is expected to provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$16.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has announced the release of its 2025 Appendix 4G and Corporate Governance Statement to the Australian Securities Exchange (ASX). This announcement is part of the company’s compliance with ASX listing rules, specifically rule 4.7.3. The release of these documents underscores McMillan Shakespeare Limited’s commitment to transparency and adherence to corporate governance standards, which may influence stakeholder confidence and the company’s market positioning.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$16.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has announced its 2025 Appendix 4E and Annual Report, detailing the company’s financial performance for the year ended June 30, 2025. This release to the Australian Securities Exchange (ASX) is a significant disclosure that provides stakeholders with insights into the company’s operational outcomes and financial health, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$16.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.